Trial · NCT00294047
Adverse events678
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
21 to 40 of 678
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Rash | General disorders | Cervarix Group | 185 | 2,881 | |
| other | Rash | General disorders | Aluminium Hydroxide Group | 124 | 2,871 | |
| other | Urticaria | General disorders | Cervarix Group | 258 | 2,881 | |
| other | Urticaria | General disorders | Aluminium Hydroxide Group | 201 | 2,871 | |
| serious | Abortion spontaneous complete | Pregnancy, puerperium and perinatal conditions | Cervarix Group | 19 | 2,881 | |
| serious | Abortion spontaneous complete | Pregnancy, puerperium and perinatal conditions | Aluminium Hydroxide Group | 16 | 2,871 | |
| serious | Abortion spontaneous incomplete | Pregnancy, puerperium and perinatal conditions | Cervarix Group | 19 | 2,881 | |
| serious | Abortion spontaneous incomplete | Pregnancy, puerperium and perinatal conditions | Aluminium Hydroxide Group | 13 | 2,871 | |
| serious | Appendicitis | Infections and infestations | Cervarix Group | 13 | 2,881 | |
| serious | Appendicitis | Infections and infestations | Aluminium Hydroxide Group | 12 | 2,871 | |
| serious | Abortion spontaneous | Pregnancy, puerperium and perinatal conditions | Cervarix Group | 13 | 2,881 | |
| serious | Abortion spontaneous | Pregnancy, puerperium and perinatal conditions | Aluminium Hydroxide Group | 12 | 2,871 | |
| serious | Uterine leiomyoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Cervarix Group | 13 | 2,881 | |
| serious | Uterine leiomyoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Aluminium Hydroxide Group | 9 | 2,871 | |
| serious | Abortion missed | Pregnancy, puerperium and perinatal conditions | Cervarix Group | 10 | 2,881 | |
| serious | Abortion missed | Pregnancy, puerperium and perinatal conditions | Aluminium Hydroxide Group | 11 | 2,871 | |
| serious | Cholelithiasis | Hepatobiliary disorders | Cervarix Group | 5 | 2,881 | |
| serious | Cholelithiasis | Hepatobiliary disorders | Aluminium Hydroxide Group | 9 | 2,871 | |
| serious | Blighted ovum | Pregnancy, puerperium and perinatal conditions | Cervarix Group | 6 | 2,881 | |
| serious | Blighted ovum | Pregnancy, puerperium and perinatal conditions | Aluminium Hydroxide Group | 7 | 2,871 |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00294047/events?page=2